Rossari Biotech logs lackluster Q1FY23 performance; Stock marginally up

PAT stood at Rs28.68 crore as against Rs24.08 crore.

Related Keywords

Edward Menezes ,Rossari Biotech ,Rossari Biotech Limited ,Executive Chairman ,Sunil Chari ,Managing Director ,Romakk Chemicals ,